CPRX
Catalyst Pharmaceuticals Inc
31.50$
+0.0%
vs. previous close
Closing price · As of: Jul 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | +20,361.3% | +16.4% | +18.3% | +52.1% | +85.9% | +23.5% | +19.8% | |
| – | – | +25.9% | +5.3% | +43,497.4% | -25.9% | +15.4% | +28.4% | +57.2% | +51.1% | +32.5% | +26.7% | |
| – | – | – | – | – | +17,409.4% | +16.5% | +16.6% | +51.2% | +92.6% | +22.1% | +18.6% | |
| – | +16.6% | -3.7% | +0.0% | +75.1% | -5.4% | -12.5% | +2.7% | +16.8% | +370.7% | -86.4% | +0.5% | |
| – | +92.2% | -8.0% | -7.7% | +117.3% | +132.3% | -44.0% | +13.6% | +22.3% | +63.8% | +256.7% | -57.4% | |
| – | +39.8% | -5.5% | -3.1% | +91.6% | +55.7% | +9.0% | +9.6% | +17.1% | +232.7% | -12.2% | +7.1% | |
| – | – | – | – | – | – | +29.8% | +26.8% | +94.4% | -14.8% | +124.8% | +32.1% | |
| – | +31.7% | +220.4% | +41.2% | +184.4% | +45.8% | -21.8% | -67.8% | +769.2% | – | – | – | |
| – | – | – | – | – | – | +25.4% | +25.7% | +98.8% | -9.7% | +128.8% | +31.1% | |
| – | -110.0% | – | – | +1,729.3% | -40.6% | -2,257.7% | – | +64.1% | +6.8% | +126.7% | +32.1% | |
| – | – | – | – | – | – | +135.2% | -47.3% | +110.4% | -14.0% | +129.5% | +30.8% | |
| – | – | – | – | – | – | +31.3% | +24.6% | +96.0% | +23.6% | +99.4% | +26.5% |
Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.